On Biostatistics and Clinical Trials

When trials don’t use a traditional control — What the FDA guidance says In the usual drug-development pathway, regulators expect a trial w...

If new drug application (NDA) or biological license application (BLA) is not approved by the FDA, the sponsor will receive a complete respon...

After the NDA/BLA is submitted to FDA, the FDA review clock starts. There are several critical dates relevant to the applicant (the sponsor)...